Inventor profile of:

Marc Allan EICHMEYER

City:

Bondurant, Iowa

Country:

United States

Published Applications:

16

Last publication date:

2018-10-11

Top Assignees for applications by Marc Allan EICHMEYER

The entities that hold a legal rights for patent applications filed by inventor EICHMEYER Marc Allan:

Recent patent applications by EICHMEYER Marc Allan

Marc Allan EICHMEYER from Bondurant, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-10-11
US20180289795A1
Human necessities

Bivalent swine influenza virus vaccine

#2 | 2018-08-23
US20180236057A1
Human necessities

Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs

#3 | 2018-06-21
US20180169214A1
Human necessities

PCV2 immunogenic compositions and methods of producing such compositions

#4 | 2018-06-21
US20180169213A1
Human necessities

Multivalent PCV2 immunogenic compositions and methods of producing such compositions

#5 | 2017-09-07
US20170253908A1
Chemistry; metallurgy

Quantification of vaccine compositions

#6 | 2017-08-17
US20170232094A1
Human necessities

PORCINE CIRCOVIRUS TYPE 2 (PCV2) SUBUNIT VACCINE

#7 | 2017-02-23
US20170049875A1
Human necessities

Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs

#8 | 2016-09-01
US20160250318A1
Human necessities

Bivalent swine influenza virus vaccine

#9 | 2016-07-07
US20160193320A1
Human necessities

Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs

#10 | 2015-10-22
US20150297708A1
Human necessities

Multivalent PCV2 immunogenic compositions and methods of producing such compositions

#11 | 2015-10-22
US20150297707A1
Human necessities

Multivalent PCV2 immunogenic compositions and methods of producing such compositions

#12 | 2015-07-09
US20150190498A1
Human necessities

Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs

#13 | 2015-02-26
US20150056248A1
Human necessities

PORCINE CIRCOVIRUS TYPE 2 (PCV2) SUBUNIT VACCINE

#14 | 2014-09-04
US20140248603A1
Chemistry; metallurgy

Quantification of vaccine compositions

#15 | 2013-04-25
US20130101621A1
Human necessities

PCV2 immunogenic compositions and methods of producing such compositions

#16 | 2011-03-10
US20110059126A1
Human necessities

Methods of reducing virucidal activity in PCV-2 compositions and PCV-2 compositions with an improved immunogenicity

InventorID:

895977 ⎘